116 related articles for article (PubMed ID: 36382626)
41. PIK3CA mutation is a favorable prognostic factor in esophageal cancer: molecular profile by next-generation sequencing using surgically resected formalin-fixed, paraffin-embedded tissue.
Yokota T; Serizawa M; Hosokawa A; Kusafuka K; Mori K; Sugiyama T; Tsubosa Y; Koh Y
BMC Cancer; 2018 Aug; 18(1):826. PubMed ID: 30115035
[TBL] [Abstract][Full Text] [Related]
42. Targeted Molecular Analysis in Adrenocortical Carcinomas: A Strategy Toward Improved Personalized Prognostication.
Lippert J; Appenzeller S; Liang R; Sbiera S; Kircher S; Altieri B; Nanda I; Weigand I; Gehrig A; Steinhauer S; Riemens RJM; Rosenwald A; Müller CR; Kroiss M; Rost S; Fassnacht M; Ronchi CL
J Clin Endocrinol Metab; 2018 Dec; 103(12):4511-4523. PubMed ID: 30113656
[TBL] [Abstract][Full Text] [Related]
43. LYmphoid NeXt-Generation Sequencing (LYNX) Panel: A Comprehensive Capture-Based Sequencing Tool for the Analysis of Prognostic and Predictive Markers in Lymphoid Malignancies.
Navrkalova V; Plevova K; Hynst J; Pal K; Mareckova A; Reigl T; Jelinkova H; Vrzalova Z; Stranska K; Pavlova S; Panovska A; Janikova A; Doubek M; Kotaskova J; Pospisilova S
J Mol Diagn; 2021 Aug; 23(8):959-974. PubMed ID: 34082072
[TBL] [Abstract][Full Text] [Related]
44. Recommendations for the clinical interpretation and reporting of copy number gains using gene panel NGS analysis in routine diagnostics.
Eijkelenboom A; Tops BBJ; van den Berg A; van den Brule AJC; Dinjens WNM; Dubbink HJ; Ter Elst A; Geurts-Giele WRR; Groenen PJTA; Groenendijk FH; Heideman DAM; Huibers MMH; Huijsmans CJJ; Jeuken JWM; van Kempen LC; Korpershoek E; Kroeze LI; de Leng WWJ; van Noesel CJM; Speel EM; Vogel MJ; van Wezel T; Nederlof PM; Schuuring E; Ligtenberg MJL
Virchows Arch; 2019 Jun; 474(6):673-680. PubMed ID: 30888490
[TBL] [Abstract][Full Text] [Related]
45. Validation of quantitative PCR-based assays for detection of gene copy number aberrations in formalin-fixed, paraffin embedded solid tumor samples.
Mehrotra M; Luthra R; Abraham R; Mishra BM; Virani S; Chen H; Routbort MJ; Patel KP; Medeiros LJ; Singh RR
Cancer Genet; 2017 Apr; 212-213():24-31. PubMed ID: 28449808
[TBL] [Abstract][Full Text] [Related]
46. Next generation MUT-MAP, a high-sensitivity high-throughput microfluidics chip-based mutation analysis panel.
Schleifman EB; Tam R; Patel R; Tsan A; Sumiyoshi T; Fu L; Desai R; Schoenbrunner N; Myers TW; Bauer K; Smith E; Raja R
PLoS One; 2014; 9(3):e90761. PubMed ID: 24658394
[TBL] [Abstract][Full Text] [Related]
47. Ultra-selection of metastatic colorectal cancer patients using next-generation sequencing to improve clinical efficacy of anti-EGFR therapy.
Vidal J; Bellosillo B; Santos Vivas C; García-Alfonso P; Carrato A; Cano MT; García-Carbonero R; Élez E; Losa F; Massutí B; Valladares-Ayerbes M; Viéitez JM; Manzano JL; Azuara D; Gallego J; Pairet S; Capellá G; Salazar R; Tabernero J; Aranda E; Montagut C
Ann Oncol; 2019 Mar; 30(3):439-446. PubMed ID: 30689692
[TBL] [Abstract][Full Text] [Related]
48. A gene expression-based model predicts outcome in children with intermediate-risk classical Hodgkin lymphoma.
Johnston RL; Mottok A; Chan FC; Jiang A; Diepstra A; Visser L; Telenius A; Gascoyne RD; Friedman DL; Schwartz CL; Kelly KM; Scott DW; Horton TM; Steidl C
Blood; 2022 Feb; 139(6):889-893. PubMed ID: 34662378
[TBL] [Abstract][Full Text] [Related]
49. Analysis of a large cohort of non-small cell lung cancers submitted for somatic variant analysis demonstrates that targeted next-generation sequencing is fit for purpose as a molecular diagnostic assay in routine practice.
Moore DA; Balbi K; Ingham A; Arkenau HT; Bennett P
J Clin Pathol; 2018 Nov; 71(11):1001-1006. PubMed ID: 30054375
[TBL] [Abstract][Full Text] [Related]
50. Recurrent genetic defects in classical Hodgkin lymphoma cell lines.
Hudnall SD; Meng H; Lozovatsky L; Li P; Strout M; Kleinstein SH
Leuk Lymphoma; 2016 Dec; 57(12):2890-2900. PubMed ID: 27121023
[TBL] [Abstract][Full Text] [Related]
51. A TaqMan low-density array to predict outcome in advanced Hodgkin's lymphoma using paraffin-embedded samples.
Sánchez-Espiridión B; Sánchez-Aguilera A; Montalbán C; Martin C; Martinez R; González-Carrero J; Poderos C; Bellas C; Fresno MF; Morante C; Mestre MJ; Mendez M; Mazorra F; Conde E; Castaño A; Sánchez-Godoy P; Tomas JF; Morente MM; Piris MA; García JF;
Clin Cancer Res; 2009 Feb; 15(4):1367-75. PubMed ID: 19228737
[TBL] [Abstract][Full Text] [Related]
52. [Clinical features and prognosis of CD20-positive classical Hodgkin lymphoma].
Qin Y; Kang SY; He XH; Zhou SY; Liu P; Yang JL; Zhang CG; Yang S; Gui L; Shi YK
Zhonghua Yi Xue Za Zhi; 2016 Jul; 96(28):2224-8. PubMed ID: 27480653
[TBL] [Abstract][Full Text] [Related]
53. Next-Generation Sequencing for Genotyping of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration Samples in Lung Cancer.
Xie F; Zheng X; Mao X; Zhao R; Ye J; Zhang Y; Sun J
Ann Thorac Surg; 2019 Jul; 108(1):219-226. PubMed ID: 30885850
[TBL] [Abstract][Full Text] [Related]
54. Cytology smears as excellent starting material for next-generation sequencing-based molecular testing of patients with adenocarcinoma of the lung.
Velizheva NP; Rechsteiner MP; Wong CE; Zhong Q; Rössle M; Bode B; Moch H; Soltermann A; Wild PJ; Tischler V
Cancer Cytopathol; 2017 Jan; 125(1):30-40. PubMed ID: 27636102
[TBL] [Abstract][Full Text] [Related]
55. Mediastinal gray zone lymphoma: the missing link between classic Hodgkin's lymphoma and mediastinal large B-cell lymphoma.
Traverse-Glehen A; Pittaluga S; Gaulard P; Sorbara L; Alonso MA; Raffeld M; Jaffe ES
Am J Surg Pathol; 2005 Nov; 29(11):1411-21. PubMed ID: 16224207
[TBL] [Abstract][Full Text] [Related]
56. Consistency and reproducibility of next-generation sequencing and other multigene mutational assays: A worldwide ring trial study on quantitative cytological molecular reference specimens.
Malapelle U; Mayo-de-Las-Casas C; Molina-Vila MA; Rosell R; Savic S; Bihl M; Bubendorf L; Salto-Tellez M; de Biase D; Tallini G; Hwang DH; Sholl LM; Luthra R; Weynand B; Vander Borght S; Missiaglia E; Bongiovanni M; Stieber D; Vielh P; Schmitt F; Rappa A; Barberis M; Pepe F; Pisapia P; Serra N; Vigliar E; Bellevicine C; Fassan M; Rugge M; de Andrea CE; Lozano MD; Basolo F; Fontanini G; Nikiforov YE; Kamel-Reid S; da Cunha Santos G; Nikiforova MN; Roy-Chowdhuri S; Troncone G;
Cancer Cytopathol; 2017 Aug; 125(8):615-626. PubMed ID: 28475299
[TBL] [Abstract][Full Text] [Related]
57. Fibroblast growth factor-2 (FGF2) and syndecan-1 (SDC1) are potential biomarkers for putative circulating CD15+/CD30+ cells in poor outcome Hodgkin lymphoma patients.
Gharbaran R; Goy A; Tanaka T; Park J; Kim C; Hasan N; Vemulapalli S; Sarojini S; Tuluc M; Nalley K; Bhattacharyya P; Pecora A; Suh KS
J Hematol Oncol; 2013 Aug; 6():62. PubMed ID: 23988031
[TBL] [Abstract][Full Text] [Related]
58. The histologic, immunohistochemical, and genetic features of classical Hodgkin lymphoma and anaplastic large cell lymphoma with aberrant T-cell/B-cell antigen expression.
Liang K; Wang J; Wang Y; Zhou Z; Ge S; Mei S; Li H; Jing X; Zhang C
Hum Pathol; 2019 Feb; 84():309-320. PubMed ID: 30339972
[TBL] [Abstract][Full Text] [Related]
59. Clinicopathologic and prognostic significance of c-MYC copy number gain in lung adenocarcinomas.
Seo AN; Yang JM; Kim H; Jheon S; Kim K; Lee CT; Jin Y; Yun S; Chung JH; Paik JH
Br J Cancer; 2014 May; 110(11):2688-99. PubMed ID: 24809777
[TBL] [Abstract][Full Text] [Related]
60. Quantitative Analysis of Carbonic Anhydrase IX Uncovers Hypoxia-Related Functional Differences in Classical Hodgkin Lymphoma Subtypes.
Matolay O; Beke L; Gyurkovics A; Francz M; Varjasi G; Rejtő L; Illés Á; Bedekovics J; Méhes G
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31311071
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
